Dr. med. Wolf Rösler


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2024) Maffini E, Labopin M, Kröger N, Finke J, Stelljes M, Schroeder T, Einsele H, et al. Journal article Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023) Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al. Journal article The utility of biomarkers in acute GVHD prognostication (2023) Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al. Journal article Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD (2023) Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, et al. Journal article Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023) Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al. Journal article, Letter Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use (2023) Weber D, Weber M, Meedt E, Ghimire S, Wolff D, Edinger M, Poeck H, et al. Journal article Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT (2023) Karl F, Liang C, Böttcher-Loschinski R, Stoll A, Flamann C, Richter S, Lischer C, et al. Journal article CD19-targeted CAR T cells in refractory antisynthetase syndrome (2023) Müller F, Böltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, et al. Journal article Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia A Randomized Clinical Trial (2023) Bornhaeuser M, Schliemann C, Schetelig J, Roellig C, Kramer M, Glass B, Platzbecker U, et al. Journal article Effective treatment of low-risk acute GVHD with itacitinib monotherapy (2023) Etra A, Capellini A, Alousi A, Al Malki MM, Choe H, DeFilipp Z, Hogan WJ, et al. Journal article